News Articles

Trading Room

100+ Years of combined Market Experience!

Current Strategy and Tactics

Here are some conclusions I have reached with a high degree of confidence on the macro picture, plus a few stock and sector ideas thrown in. 
By Jeff Miller

chart

Kohl's Analysis After the Dip

Our final in a series of articles about the retail industry focuses on Kohl’s (KSS), which reported earnings today and dropped by about 7% to about $45/share. It is potentially a deep value opportunity, but one that comes with considerable risk.
By Lyn Alden Schwartzer

chart

Shorting Solid Biosciences Stock (SLDB)

Solid Biosciences (SLDB) stock was up 43% on Friday after an upgrade to Buy by Chardan Capital’s analyst Gbola Amusa. Meanwhile, insiders have been selling the stock all year, including the management.
By Bhavneesh Sharma

chart

In Risk-Off Markets All Asset Prices Tend To Go Lower And Create Opportunity

History teaches us that the best time to buy stocks and commodities is when fear reaches a peak. For the coming weeks and months, tight stops and discipline will allow for bargain hunting when others are calling market swoons financial Armageddon.
By Andy Hecht

chart

Tapestry’s Massive Sell-off: Opportunity or Trap?

Earlier this month, I wrote a broad overview of the struggling retail industry, where I discussed the various problems affecting certain retail companies, including Tapestry (TPR), whose stock is down 20% after reporting earnings today.
By Lyn Alden Schwartzer

chart

Aurinia Pharmaceuticals (AUPH): Trading Strategy Ahead of Phase 3 Trial Results for Lupus Nephritis Treatment

The company's Phase 3 trial results for voclosporin in treating lupus nephritis (LN) will likely come in November.
By Bhavneesh Sharma

chart

Bullish Bonanza In Precious Metals

Over the past week, both metals rallied to higher highs as the buying continues to usher in a new era of luster for gold and silver.
By Andy Hecht

chart

My Favorite International ETF

Vanguard’s newer International Dividend Appreciation ETF (ticker: VIGI) is an international ETF I like a lot going forward as part of a diversified portfolio. It invests in international companies that have at least 7 years of consecutive annual dividend growth.
By Lyn Alden Schwartzer

Causal Modeling for Current Economic Issues

Everyone in the investment world knows that correlation does not equal causation. That knowledge does not inoculate them against errors!
By Jeff Miller

chart

Employment Report: Under The Hood

The employment report released last Friday showed material weakness behind the headline addition of 164,000 jobs.
By Eric Basmajian

chart

Notes On Esperion Therapeutics: Buy/Sell Or Hold?

Esperion Therapeutics has a key compound called Bempedoic acid (BPA) that lowers LDL cholesterol (LDL-C) by a different mechanism than statins. Once the Adcom window has passed later this year, short-term traders could attempt to play a run-up in the stock before PDUFA.
By Bhavneesh Sharma

chart

Central Bank Accommodation Is An Addiction

While the global financial crisis of 2008 has faded in the market’s rearview mirror, the world’s central banks remain addicted to stimulus.
By Andy Hecht

chart

Looking For Quality Among the Retail Apocalypse

The retail industry is a mess right now, but investors should think of it less as online vs physical retail at this point and start thinking in terms of which omnichannel retailers will survive over the next decade. Which physical retailers are showing good success at shifting their sales to online distribution, or appealing to discount physical shoppers, while maintaining decent returns on capital in a tough environment?
By Lyn Alden Schwartzer

chart

Chiasma Stock Could See More Downside

Chiasma (CHMA) recently reported successful phase 3 data for its oral octreotide formulation, Mycapssa, in treating acromegaly (a syndrome due to excessive growth hormone). The stock had a brief pop and has pulled back after the announcement of a $55M secondary equity offering. I looked at the company and feel that the stock has more room to fall in the coming months.
By Bhavneesh Sharma

chart

Precious Metals And The Strong Dollar

Is a strong dollar mutually exclusive with a bull market in precious metals prices? The answer may be no when all currencies in the world are losing value.
By Andy Hecht

Bitcoin: 5-10 Year Outlook

Bitcoin’s support level will rise over time, and therefore a strategic entry is important to withstand volatility and hold the asset over the next 5-10 years.
By Beth Kindig

chart

Snap-on is Becoming Attractively Priced

Snap-on Incorporated (SNA) is starting to look interesting from a valuation standpoint. I’m about to move it from my watch list to my active portfolio to begin dollar-cost averaging into it with a small position.
By Lyn Alden Schwartzer

chart

When Will Lower Mortgage Rates Lift The Housing Market?

Today's data on newly constructed single-family home sales was, on balance, weaker than expectations. Despite lower mortgage rates, the housing market is struggling to gain traction, decelerating on a trending basis across most categories including building permits, and new home sales to name a couple.
By Eric Basmajian

chart

Should We Worry About Mounting Debt?

While I am not troubled by individual and corporate debt (stories for another day) government debt is another matter.
By Jeff Miller

chart

The BNB Token

One of the strongest ‘alt coins of this year has been Binance coin (BNB).
By Ryan Wilday

chart

Silver And Oil- A Tale Of Two Directions

In the world of commodities, most market participants pay most attention to the crude oil and precious metals markets. This past week, gold and silver headed higher while the energy commodity went the other way.
By Andy Hecht

chart

It's Time to Take a Look at Invesco

Invesco is the 13th largest asset manager in the world and offers a variety of products for passive and active investors. They operate the popular QQQ ETF and a variety of factor-based ETF strategies. I particularly like their lead in equal-weight strategies.
By Lyn Alden Schwartzer

chart

Market Highs: Where is Your Portfolio?

If you are a long-term investor, your portfolio should reflect your personal needs and goals, risk tolerance, and market conditions. There are many reasons why you should not be “beating the market.” Here are some of the most important.
By Jeff Miller

chart

Building Permits Tumble In June - Are The Low Interest Rates Helping?

The housing starts and building permits report is one of my favorite data points on the housing market and can also be one of the earliest leading indicators in the economy.
By Eric Basmajian